Broadwood Partners Condemns Alcon's Fallacious Attacks on STAAR Surgical and Its Prospects
Reminds STAAR's Board That It Does Not Need Alcon's Permission to Remain Independent or Run a Proper Strategic Alternatives Process NEW YORK — Broadwood Partners, L.P. and its affiliates ("Broadwood" or "we") today commented on the investor presentation issue
(Financial Post, 2025-11-04T16:52:10Z)